Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | BTN3A1 | O00481 | 4/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | MMP1 | P03956 | 2/20 | 0.33 |
| ▸ | MMP3 | P08254 | 2/20 | 0.33 |
| ▸ | MMP8 | P22894 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL7261093 | 1.00 | ALDH1A1 (0.41) | ALDH1A1TDP1TRPA1BTN3A1CA2 | |
| SCHEMBL1870277 | 0.84 | — | — | |
| SCHEMBL19043 | 0.84 | — | — | |
| SCHEMBL5612211 | 0.84 | ALDH1A1 (0.54) | ALDH1A1TDP1TRPA1LMNATSHR | |
| SCHEMBL8356772 | 0.84 | ALDH1A1 (0.54) | ALDH1A1TDP1TRPA1LMNATSHR | |
| SCHEMBL15327802 | 0.84 | ALDH1A1 (0.54) | ALDH1A1TDP1TRPA1LMNATSHR | |
| Phosphoric Acid SCHEMBL4552755 | 0.84 | TSHR (0.45) | ALDH1A1TDP1BTN3A1TSHR | |
| Pyrophosphoric Acid SCHEMBL7261095 | 0.82 | TDP1 (0.56) | ALDH1A1TDP1BTN3A1BLM | |
| Acetone SCHEMBL5270050 | 0.81 | LMNA (0.55) | ALDH1A1TDP1TRPA1LMNAKDM4E | |
| Methyl Alcohol SCHEMBL9228678 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113528362-A | Recombinant acid-tolerant yeast with inhibited glycerol production and method for producing lactic acid using the same | SK新技术株式会社 | 2021-10-22 | — | — | CN | claimed |
| US-20210324346-A1 | RECOMBINANT ACID-RESISTANT YEAST WITH SUPPRESSED GLYCEROL PRODUCTION AND METHOD OF PRODUCING LACTIC ACID USING THE SAME | SK INNOVATION CO., LTD. (KR) | 2021-10-21 | — | — | US | claimed |
| EP-3896166-A1 | RECOMBINANT ACID-RESISTANT YEAST WITH SUPPRESSED GLYCEROL PRODUCTION AND METHOD OF PRODUCING LACTIC ACID USING THE SAME | SK Innovation Co., Ltd. (KR) | 2021-10-20 | — | — | EP | claimed |
| EP-3814515-A2 | ENGINEERED MICROORGANISMS WITH G3P---> 3PG ENZYME AND/OR FRUCTOSE-1,6-BISPHOSPHATASE INCLUDING THOSE HAVING SYNTHETIC OR ENHANCED METHYLOTROPHY | Genomatica, Inc. (US) | 2021-05-05 | — | — | EP | claimed |
| US-20170306389-A1 | NOVEL MEASURING METHOD AND COMPOSITION USING KINASE | ASAHI KASEI PHARMA CORPORATION (JP) | 2017-10-26 | — | — | US | claimed |
| EP-3199639-A1 | NOVEL MEASUREMENT METHOD USING KINASE, AND COMPOSITION | Asahi Kasei Pharma Corporation (JP) | 2017-08-02 | — | — | EP | claimed |
| WO-2008148640-A1 | MICROBIOLOGICAL PRODUCTION OF ALDEHYDES, ESPECIALLY OF 3-HYDROXYPROPIONALDEHYDE | EVONIK DEGUSSA GMBH (DE) | 2008-12-11 | — | — | WO | claimed |
| WO-2001077366-A1 | POSITIVE SELECTION METHOD, COMPOUNDS, HOST CELLS AND USES THEREOF | CUBIST PHARMACEUTICALS, INC. (US) | 2001-10-18 | — | — | WO | claimed |
| EP-0815847-B1 | Cosmetic and/or dermatological composition containing at least an active agent precursor and a crosslinked polymer of 2-acrylamide-2-methylpropane sulfonic acid | OREAL (FR) | 1999-04-14 | — | — | EP | claimed |
| EP-0669126-B1 | Stabilized emulsion for hydrating the skin | OREAL (FR) | 1999-01-27 | — | — | EP | claimed |
| CN-119979580-A | Method for producing 1, 3-dihydroxyacetone | 中国科学院天津工业生物技术研究所 | 2025-05-13 | — | — | CN | disclosed |
| WO-2025072741-A1 | PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-04-03 | — | — | WO | disclosed |
| US-12157902-B2 | Recombinant acid-resistant yeast with suppressed glycerol production and method of producing lactic acid using the same | SK INNOVATION CO., LTD. (KR) | 2024-12-03 | — | — | US | disclosed |
| WO-2024137704-A2 | PROCESSES FOR PRODUCING FERMENTATION PRODUCTS USING FIBER-DEGRADING ENZYMES WITH ENGINEERED YEAST | NOVOZYMES A/S (DK) | 2024-06-27 | — | — | WO | disclosed |
| WO-2024059834-A2 | DOWNREGULATING INOS TO INCREASE CAR-T KILLING | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC. (US) | 2024-03-21 | — | — | WO | disclosed |
| EP-0669126-A1 | Stabilized emulsion for hydrating the skin | L'OREAL (FR) | 1995-08-30 | — | — | EP | disclosed |
| US-5393879-A | Fructosyl C-glycoside nucleoside analogs | THE SCRIPPS RESEARCH INSTITUTE (US) | 1995-02-28 | — | — | US | disclosed |
| WO-1991015597-A1 | PROCEDURE FOR DETERMINATION OF CLINICALLY SIGNIFICANT METABOLITES | ELOMIT OY (FI) | 1991-10-17 | — | — | WO | disclosed |
| EP-0179442-A2 | Stabilized composition containing inositoltriphosphate and method for stabilizing the composition | PERSTORP AB (SE) | 1986-04-30 | — | — | EP | disclosed |
| EP-0019253-A1 | Test device, composition and method for the determination of triglycerides | MILES LABORATORIES, INC. (US) | 1980-11-26 | — | — | EP | disclosed |